Nurse-led Primary Healthcare Intervention Model in Women's Health Management in Hong Kong
JCDATAZONEWH
1 other identifier
interventional
1,728
1 country
3
Brief Summary
The goal of this randomized clinical trial is to learn if a nurse-led primary healthcare intervention can help improve health management in women adults aged 45 to 64, and to develop an evidence-based primary healthcare model for women. The questions it aims to answer are: if the intervention improves medical resource use, especially at 3-month from the beginning of intervention? if the intervention improves health confidence, self-management, and quality-of-life? if the intervention improves health conditions as reflected by risk levels? Researchers will compare the intervention with the control group over time to see if there are better medical resource use, health confidence, self-management, and quality-of-life, and health conditions risk levels. All participants will be asked to answer a set of questionnaires assessing their social demographics, health-related status, and risk levels of the targeted health conditions. All participants will receive an education booklet containing essential knowledge and available medical resources. Participants in the intervention group will receive nurse-led 5As (ask, advice, assess, assist, arrange) intervention which offers risk-specific health services. Participants will be followed at 3-, 6-, 12-month; with high risk participants will be followed additionally at 1-month after the beginning of intervention. Participants in the waitlist control group will be given general health advice as minimal intervention, followed-up at 3- and 6-month, provided with intervention of the same content with intervention group at 6-month, followed-up at 7-month and 12-month.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2024
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2024
CompletedStudy Start
First participant enrolled
October 4, 2024
CompletedFirst Posted
Study publicly available on registry
October 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 26, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 26, 2027
April 29, 2026
April 1, 2026
1.6 years
September 27, 2024
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of medical resource utilization
Defined as completion of any referral (Women Health Centres or Maternal and Child Health Centres listed by the Depratment of Health, Kwong Wah Hospital Well Women Clinic, Tung Wah Group of Hospitals Well Women Clinic (North Point), Hong Kong Adventis Hospital Well Women Clinic, Women's Health Service by The Family Planning Association of Hong Kong, Canossa Hospital Health Check Centre, Primary Healthcare Directory Doctors, Hong Kong Breast Cancer Foundation Jockey Club Holistic Breast Health Project, Chronic-Disease Co-Care Pilot Scheme by Distric Health Centres, Colorectal Cancer Screenings (including Fecal Occult Blood Test, Sigmoidoscopy, or Colonoscopy), Jockey Club Holistic Support Project for Elderly Mental Wellness (JC JoyAge), or Integrated Community Centre for Mental Wellness) for consultation, prescriptions, screening, therapy, etc targeting health condition of concerns. A binary result with either "Yes" or "No" will be recorded.
3-month from baseline
Secondary Outcomes (16)
Rate of medical resource utilization
1- , 6-, 7-, and 12-month after baseline.
Characteristics of medical resource utilization
1- , 6-, 7-, and 12-month after baseline.
Score of self-reported Health Confidence Scale (HCS)
1- , 3-, 6-, 7-, and 12-month after baseline.
Score of self-reported Self-Management Assessment Scale (SMASc)
1- , 3-, 6-, 7-, and 12-month after baseline.
Score in HK Chinese version of the EQ-5D-5L instrument (EQ-5D-5L HK) measuring quality of life
1- , 3-, 6-, 7-, and 12-month after baseline.
- +11 more secondary outcomes
Study Arms (2)
Minimal intervention
ACTIVE COMPARATORParticipants allocated to the control group condition will be given minimal intervention in standard practices at baseline and 3-month. It consist of general health education and advice, where the health information is open resources available for the public. No risk-stratified services nor active referral will be conducted by nurse until 6-month assessment is completed. After that, they will immediately receive intervention based on their 6-month assessment, and booster interventions at 7-month contact and 12-month follow-up.
Nurse-led Risk-based 5As Intervention Arm
EXPERIMENTALParticipants allocated to the intervention condition will receive the nurse-led 5As model intervention at baseline, 1- and 3-month boosters, and 6- and 12-month follow-ups. The current model includes risk assessments and stratification, general health education booklet, consultations and active referrals based on personal risk stratification at baseline and 3-month booster, with additional booster session at 1-month, and follow-up sessions at 6- and 12-month from baseline. For participants with high risk of any target health conditions at baseline and 3-month booster, medical referral and service utilization (e.g., GPs/network doctors/specialist consultation at health centres/hospitals/clinics, screening, therapies, corresponding District Health Centre schemes, etc.) will be arranged at the visits. Such medical resource utilization among participants will be encouraged and motivated at 1-month booster session.
Interventions
The intervention is developed based on the 5As model (ask, advice, assess, assist, arrange). In this model, nurse will play the central role in delivering the service as a case manager. In Ask, all participants will be assessed on the demographics, health related status, and health risk stratification (i.e. 3-tier risk stratification). In Advice, all participants will be given the education booklet. Those assessed to be at low risks will receive general advice, while those at medium risk will receive condition-specific advice instead. High risk participants will be provided with referral suggestions. The assessment of medium or high risk participants willingness and any barriers in seeking changes will be conducted in Assess. In Assist, active referrals will be provided to high risk participants, with weekly advice messages provided to medium and high risk participants. In Arrange, all participants will receive their follow-ups.
Consisting general advice on women health with the education booklet. No risk-based services nor active referral will be offered during the waitlist control exposure. Participants will be switched to receive intervention from 6-month.
Eligibility Criteria
You may qualify if:
- Hong Kong female residents aged 45 to 64 years old; and
- Able to read and communicate in Chinese (either Cantonese or Mandarin).
You may not qualify if:
- Have a terminal illness (e.g., advanced cancer, dementia, pulmonary, neurological, motor-neuron, and advanced cardiovascular disease), or with a life expectancy of less than six months;
- Diagnosed with psychiatric or psychological disorders (e.g., panic disorder, psychosis);
- Currently taking medication(s) or receiving treatment(s) for psychiatric and psychological disorders;
- Pregnant or in lactation period, or have plans for pregnancy within 1 year; or
- Have moderate or severe cognitive impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Hong Konglead
- The Hong Kong Jockey Club Charities Trustcollaborator
- Hong Kong Sheng Kung Hui Welfare Council Limitedcollaborator
- Aberdeen Kai-fong Welfare Associationcollaborator
- Haven of Hope Hospitalcollaborator
Study Sites (3)
Aberdeen Kaifong Welfare Association
Hong Kong, HONG KONG, 999077, Hong Kong
Haven of Hope Christian Service
Hong Kong, HONG KONG, 999077, Hong Kong
Hong Kong Sheng Kung Hui Welfare Council
Hong Kong, HONG KONG, 999077, Hong Kong
Related Publications (8)
Nasreen SZA: Management of Menopause: Jaypee Brothers Medical Publishers; 2021.
BACKGROUNDSaitz R, Alford DP, Bernstein J, Cheng DM, Samet J, Palfai T. Screening and brief intervention for unhealthy drug use in primary care settings: randomized clinical trials are needed. J Addict Med. 2010 Sep;4(3):123-30. doi: 10.1097/ADM.0b013e3181db6b67.
PMID: 20936079BACKGROUNDSlev VN, Molenkamp CM, Eeltink CM, Roeline W Pasman H, Verdonck-de Leeuw IM, Francke AL, van Uden-Kraan CF. A nurse-led self-management support intervention for patients and informal caregivers facing incurable cancer: A feasibility study from the perspective of nurses. Eur J Oncol Nurs. 2020 Apr;45:101716. doi: 10.1016/j.ejon.2019.101716. Epub 2020 Jan 20.
PMID: 32023503BACKGROUNDKolac N, Yildiz A. The effect of health belief model-based short interviews in women in the postmenopausal period on the prevention of osteoporosis: A randomized controlled trial. Int J Nurs Pract. 2023 Feb;29(1):e13121. doi: 10.1111/ijn.13121. Epub 2022 Dec 16.
PMID: 36524466BACKGROUNDWang MP, Luk TT, Wu Y, Li WH, Cheung DY, Kwong AC, Lai V, Chan SS, Lam TH. Chat-based instant messaging support integrated with brief interventions for smoking cessation: a community-based, pragmatic, cluster-randomised controlled trial. Lancet Digit Health. 2019 Aug;1(4):e183-e192. doi: 10.1016/S2589-7500(19)30082-2. Epub 2019 Jul 31.
PMID: 33323188BACKGROUNDLi C, Liu Y, Xue D, Chan CWH. Effects of nurse-led interventions on early detection of cancer: A systematic review and meta-analysis. Int J Nurs Stud. 2020 Oct;110:103684. doi: 10.1016/j.ijnurstu.2020.103684. Epub 2020 Jun 12.
PMID: 32702568BACKGROUNDChłoń-Domińczak A, Kotowska IE, Kurkiewicz J, Abramowska-Kmon A, Stonawski M: Population ageing in Europe: facts, implications and policies. Brussels: European Commission 2014
BACKGROUNDUnited Nations. World Population Ageing 2017 Highlights (ST/ESA/SER.A/397). Population Division World Population Ageing. 2017.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Siu Chee Chan, Professor
The University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 27, 2024
First Posted
October 8, 2024
Study Start
October 4, 2024
Primary Completion (Estimated)
May 26, 2026
Study Completion (Estimated)
February 26, 2027
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
The de-identified individual participant data collected during the trial will be shared at 2 years after article publication with no end date.